FDA NDC Directory · JSON-LD · Markdown

Temozolomide

NDC 16729-051 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerAccord Healthcare Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA201528
Dosage form / routeCAPSULE · ORAL
Active ingredientsTEMOZOLOMIDE (250 mg/1)
Marketing started20170307
Package count1

External sources

Source: openFDA. Public-domain (CC0).